Next, all variables, including gender, sex, baseline hematoma volume, hematoma location, time from onset to initial NCCT, GCS scores, NIHSS scores at baseline, spot signs, HE, SBP, and hs-CRP levels, were applied into a stepwise-forward logistic regression for the clinical outcome 1 year after ICH. This evidence concerns the gene CRP and hematoma.